EUCTR2009-011625-13-NL进行中（未招募）不适用
PSOGEN:Effect adalimumab op zelfbeeld en seksueel functioneren bij matige en ernstige psoriasis van de anogenitale regio; prospectief, open label pilot onderzoek - PSOGE
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- Abbott
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patient has moderate to severe anogenital psoriasis.
- •Patient is over 18 years old.
- •Patient is heterosexual.
- •Treatment with adalimumab is to be started by attending dermatologist.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Patient is unwilling to participate.
- •Patient is homosexual.
- •Patient is younger than 18 years.
研究者
相似试验
招募中
3 期
Adalimumab effect on COVID-19IRCT20171105037262N4Bagheiat-allah University of Medical Sciences100
进行中（未招募）
不适用
The effect of Six months Adalimumab Treatment on Sick Leaves and retirement in Patients with rheumatoid Arthritis who are at risk of losing their ability to work”Rheumatoid arthritisEUCTR2009-017325-19-FIHelsingin reumakeskus
已完成
不适用
Trough level related side-effects of adalimumab therapy in patients with inflammatory bowel disease in clinical and biochemical remission, a cross-sectional cohort studyinflammatory bowel disease10017969NL-OMON40963Academisch Medisch Centrum40
尚未招募
2 期
The effect of Adalimumab in the treatment of patients with chronic schizophreniaSchizophrenia.SchizophreniaIRCT20090117001556N126Tehran University of Medical Sciences50
进行中（未招募）
1 期
Study to Evaluate the Safety and Efficacy of Adalimumab in MPS I, II, and VIMucopolysaccharidosis IMucopolysaccharidosis IIMucopolysaccharidosis VINCT03153319Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center14